These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15896895)

  • 1. Limited good and limited vision: multidrug-resistant tuberculosis and global health policy.
    Yong Kim J; Shakow A; Mate K; Vanderwarker C; Gupta R; Farmer P
    Soc Sci Med; 2005 Aug; 61(4):847-59. PubMed ID: 15896895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
    Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS
    Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOTS expansion: will we reach the 2005 targets?
    Véron LJ; Blanc LJ; Suchi M; Raviglione MC
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):139-46. PubMed ID: 14974757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
    Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
    Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant TB poses global health threat, new report also finds TB control programs effective.
    Monday Dev; 1997 Nov; 15(22):4-5. PubMed ID: 12292816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TB deaths reach historic levels. International (global).
    AIDS Wkly Plus; 1996 Apr 8-15; ():14-6. PubMed ID: 12320054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global incidence of multidrug-resistant tuberculosis.
    Zignol M; Hosseini MS; Wright A; Weezenbeek CL; Nunn P; Watt CJ; Williams BG; Dye C
    J Infect Dis; 2006 Aug; 194(4):479-85. PubMed ID: 16845631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP
    Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistance in tuberculosis].
    Winje BA; Mannsåker T; Langeland N; Heldal E
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.